SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001308179-24-000232
Filing Date
2024-03-22
Accepted
2024-03-22 08:01:36
Documents
6

Document Format Files

Seq Description Document Type Size
1 AMNEAL PHARMACEUTICALS, INC. - DEFA14A lamrx2024_defa14a.htm DEFA14A 9243
2 GRAPHIC check.jpg GRAPHIC 1441
3 GRAPHIC logo.jpg GRAPHIC 18550
4 GRAPHIC notice_1.jpg GRAPHIC 381287
5 GRAPHIC notice_2.jpg GRAPHIC 267791
6 GRAPHIC uncheck.jpg GRAPHIC 1060
  Complete submission text file 0001308179-24-000232.txt   933765
Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Filer) CIK: 0001723128 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38485 | Film No.: 24773136
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)